Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02919982 · ClinicalTrials.gov registry record
Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation
A clinical trial of Nonvalvular Atrial Fibrillation, sponsored by Baim Institute for Clinical Research.
- Completed
- Registry status
- 817
- Enrollment target
- 20
- Study locations
NCT02919982 is a study of Nonvalvular Atrial Fibrillation that has completed, run by Baim Institute for Clinical Research. The registered enrollment target is 817 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT02919982, a study of Nonvalvular Atrial Fibrillation, has completed, sponsored by Baim Institute for Clinical Research.
- COMPLETED
- Registry status
- 817 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to establish a benchmark for rate of prescription of oral anticoagulants (OA) in patients with non-valvular atrial fibrillation (NVAF) seen in an ambulatory care setting, based on independent medical assessment of clinical data and physician and patient surveys. The study will also assess reasons for not prescribing OA to prevent thromboembolic complications in patients with NVAF seen in ambulatory care, and patients' perspectives of non-use of OA for treatment of NVAF.
Conditions Studied
Study Locations (20)
Florida
- Clearwater Cardiovascular & Interventional Consultants MD PA - Clearwater
- Holy Cross Hospital, Inc. - Fort Lauderdale
- Heartwell LLP - Miami
- Cardiac Institute of the Palm Beaches - Palm Beach Gardens
Michigan
- Michigan Heart - St. Joseph Mercy Health System - Ann Arbor
- Munson Medical Group - Traverse City
Texas
- The Heart Institute of East Texas - Lufkin
- Waco Cardiology Associates - Waco
Virginia
- Centra Health, Inc. dba Stroobants Cardiovascular Center - Lynchburg
- Virginia Cardiovascular Specialists - Richmond
Alaska
- Alaska Heart Institute - Anchorage
California
- Orange County Heart Institute and Research Center - Orange
Illinois
- Adventist Health Partners, Inc. Amita Health - Hinsdale
Maryland
- Delmarva Heart LLC - Salisbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 817 participants |
| Start Date | 2017-01 |
| Est. Completion | 2019-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02919982
The ClinicalTrials.gov registry entry for NCT02919982 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 817 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baim Institute for Clinical Research, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nonvalvular Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.
NCT02919982 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Florida, Michigan, Texas.
Frequently Asked Questions
What is clinical trial NCT02919982 about?
NCT02919982 is a clinical study titled "Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation". The purpose of this study is to establish a benchmark for rate of prescription of oral anticoagulants (OA) in patients with non-valvular atrial fibrillation (NVAF) seen in an ambulatory care setting, based on independent medical assessment of clinical data and physician and patient surveys. The stud...
What is the current status of trial NCT02919982?
This trial is currently completed. The enrollment target is 817 participants. The study started on 2017-01. Estimated completion is 2019-09.
What conditions does trial NCT02919982 study?
This clinical trial studies the following conditions: Nonvalvular Atrial Fibrillation.
Who is sponsoring clinical trial NCT02919982?
This trial is sponsored by Baim Institute for Clinical Research, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02919982 being conducted?
This trial has 20 study locations across Alaska, California, Florida, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nonvalvular Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.